We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies A. Menarini Farmaceutica Internazionale SRL, Galderma UK Ltd and Pfizer Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

10.5 CPD hours

Wednesday, October 23, 2024
11:40 AM - 12:40 PM
Managing Rosacea in the era of antimicrobial stewardship

 

  • Diagnosing rosacea and briefly considering the differential of a red face
  • Flushes do not respond to antibiotics -what are our options for these?
  • Managing papulopustular (inflammatory) rosacea
 
 
 
2:00 PM - 2:45 PM
Fatty Liver: nomenclature change or something more?

 

  • Focussing on Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Prevention, screening and diagnosis
  • Devolution and our role in the community
 
 
 
3:00 PM - 3:45 PM
Guidance on milk allergy
 
 
 
 
4:00 PM - 4:30 PM
Anaphylaxis update for primary care

 

  • Taking a good history 
  • Acute management and ongoing management 
  • New developments in adrenaline delivery, at-risk groups, trends in food allergy, and guideline updates
 
 
 
4:30 PM
Conference ends
 
 
 
 
Thursday, October 24, 2024
9:30 AM - 10:25 AM
Chair's opening remarks followed by: Knee pain in primary care

 

  • Knee and hip management options
  • Practical case studies looking at injuries
  • Understanding problems that can affect knee alignment
 
 
 
10:40 AM - 11:25 AM
The role of primary care in migraine treatment: recent advances in acute and preventive approaches

 

Prescribing information for GB and NI can be found here

 

This session aims to equip primary care practitioners with the knowledge to understand:

  • The burden of migraine and how to diagnose
  • Current acute and preventive treatments for the management of migraine

Illustrative migraine case studies will be used to provide guidance on treatment scenarios

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Stores. Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PP-UNP-GBR-10299. October 2024

 

This promotional session is organised and funded by Pfizer Ltd and is intended for UK Healthcare Professionals only.
The role of primary care in migraine treatment: recent advances in acute and preventive approaches
 
11:40 AM - 12:25 PM
Assessing patients with shoulder pain

 

  • Shoulder pain – how do I work out what’s going on?
  • Common presentations and diagnoses GPs should consider
  • Examination in primary care – what tests actually help?
 
 
 
12:40 PM - 1:25 PM
Everything GPs need to know about weight loss medications

 

  • The scale and complexity of obesity in England, and why obesity deserves to be treated, not dismissed
  • The effectiveness of weight loss medications: Data and patient success stories.
  • Practical guidance on prescribing and managing side effects
     
Sponsored by:
Everything GPs need to know about weight loss medications
 
1:40 PM - 2:25 PM
Delirium management in general practice

 

  • Recognition of delirium
  • Difference between dementia and delirium
  • Care and management of delirium in the community
 
 
 
2:40 PM - 3:25 PM
Diagnosing mental health conditions in general practice

 

  • Role play demonstrating key points for a good quality mental health consultation
  • Top tips for a good mental health consultation
  • Consulting with ethnic minorities who have a mental health problem

 

 
 
 
3:40 PM - 4:25 PM
Management of gout
 
 
 
 
4:25 PM
Conference ends
 
 
 
 

Speakers